28 studies found for:    "Genital Diseases, Female" | Mexico
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Ixabepilone;   Drug: Doxorubicin;   Drug: Paclitaxel
2 Active, not recruiting TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: AMG 386 Placebo;   Drug: Paclitaxel
3 Completed A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Drug: bevacizumab [Avastin];   Drug: carboplatin
4 Recruiting Olaparib Treatment in Relapsed Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Interventions: Drug: OLAPARIB;   Drug: Single agent chemotherapy
5 Completed Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
Condition: Ovarian Cancer
Interventions: Drug: MORAb-003 (farletuzumab);   Drug: 0.9% Saline
6 Completed
Has Results
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel IUS (Mirena, BAY86-5028);   Drug: Medroxyprogesterone acetate
7 Completed
Has Results
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Conditions: Vaginitis;   Infectious Vaginosis
Interventions: Drug: Gynoclin V;   Drug: Vagitrol V
8 Terminated Fibroid Ablation Study - Large Fibroids
Conditions: Leiomyoma;   Uterine Fibroids;   Menorrhagia
Intervention: Device: VizAblate System
9 Suspended Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
Conditions: Ovarian Cysts;   Endometriosis;   Adhesions
Intervention: Biological: ADHEXIL
10 Recruiting Laparoscopic Approach to Cervical Cancer
Condition: Cervical Cancer
Interventions: Procedure: Total Abdominal Radical Hysterectomy;   Procedure: Total Laparoscopic or Robotic Radical Hysterectomy
11 Completed Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
Conditions: Cervical Cancer Recurrent or Persistent;   Palliative Treatment;   Monoclonal Antibody in Cervical Cancer Treatment
Interventions: Drug: mAb Nimotuzumab;   Device: Placebo
12 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
13 Recruiting Cervical Cancer Screening With Human Papillomavirus Testing
Conditions: CIN3;   CIN2;   Cervical Cancer
Intervention: Other: HPV screening
14 Not yet recruiting Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: Paclitaxel
15 Unknown  Hydralazine Valproate for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
16 Active, not recruiting Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
Condition: Menorrhagia
Interventions: Device: Aurora Endometrial Ablation;   Device: Rollerball Ablation/Resection
17 Unknown  Hydralazine Valproate for Cervical Cancer
Condition: Metastatic Cervical Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
18 Completed
Has Results
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix
Condition: Cancer of Cervix
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Radiation: Brachytherapy;   Radiation: Pelvic radiation
19 Completed Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Procedure: Punch biopsy of the primary tumor
20 Terminated
Has Results
Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding
Conditions: Menorrhagia;   Uterine Fibroids
Intervention: Device: Doppler-Guided Uterine Artery Occlusion Device (DUAO)

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years